On the other hand, Luiken et al. have found that high HES5 expression predicts better survival in a small cohort of patients with hepatocellular carcinoma and that HES5 over-expression suppresses MYC-induced hepato-carcinogenesis in mice [38]. The gene discussed is MYC; the disease is hepatocellular carcinoma.